nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2015, 08, v.38 1011-1013+1017
骨代谢生化指标在糖皮质激素诱导类风湿性关节炎骨质疏松症中的意义
基金项目(Foundation): 新疆医学动物模型研究重点实验室开放课题(XJDX1103-2012-07)
邮箱(Email):
DOI:
摘要:

目的探讨骨代谢生化指标的检测在糖皮质激素诱导类风湿性关节炎骨质疏松症(osteoporosis,OP)中的作用。方法选择2013年5月-2014年5月在新疆医科大学第一附属医院风湿免疫科住院的55例类风湿性关节炎(rheumatoid arthritis,RA)患者,按入院前是否已经接受糖皮质激素治疗分为治疗组(已接受激素治疗)23例和非治疗组(未接受激素治疗)32例,所有患者均进行骨密度测定及血清25羟维生素D(25OHD)、骨钙素、血钙、血磷和血碱性磷酸酶的检测,并进行比较。结果治疗组骨钙素显著低于非治疗组患者,差异有统计学意义(P<0.01),而两组患者骨密度、血清25OHD、血钙、血磷和血碱性磷酸酶指标差异均无统计学意义(P>0.05)。结论骨代谢生化指标的降低可以较早提示骨代谢的变化,其改变早于骨密度,可以敏感地反映短期内的骨代谢情况,稳定性好,有利于RA患者治疗同时监测糖皮质激素治疗后的骨代谢紊乱情况,对RA患者的早期预防和治疗骨质疏松有指导意义。

Abstract:

Objective To explore the role of bone metabolism in glucocorticoid-induced osteoporosis in rheumatoid arthritis. Methods 55 cases of rheumatoid arthritis( rheumatoid arthritis,RA) patients in the Division of Rheumatology of the First Affiliated Hospital of Xinjiang Medical University from May 2013 to May 2014 were selected as the subjects. The patients were divided into 23 cases of treated group and 32 cases of untreated group according to whether they received treatment of glucocorticoid therapy or not before hospitalization. All patients underwent a bone mineral density,serum 25-hydroxyvitamin D(25OHD),osteocalcin,calcium,phosphorus and blood alkaline phosphatase detection,and the results were compared. Results The osteocalcin in the treatment group was significantly lower than that in untreated group and the difference was statistically significant( P < 0. 01). Bone mineral density,serum 25 OHD,calcium,phosphorus and alkaline blood phosphatase indicators were not statistically significant( P > 0. 05). Conclusion The decrease of bone metabolism may indicate changes in bone metabolism earlier than bone density,thus sensitively reflecting the bone condition in the short term. The bone metabolism markers may help monitor the treatment on the RA patient and predict the bone metabolism disorder after the treatment.Therefore,the observation of bone metabolism markers is useful in early prevention and treatment of osteoporosis.

参考文献

[1]Rizzoli R,Adachi JD,Cooper C,et al.Management of glucocorticoid induced osteporosis[J].Calcif Tissue Int,2012,36(2):783-788.

[2]Mateo L,Nolla JM,Bonnin MR,et al.Sex hormone status and bone mineral density in men with rheumatoid arthritis[J].Rheumatology,1995,22(8):1455-1460.

[3]Sambrook P,Raj A,Hunter D,et al.Osteoporosis with low dose corticosteroids:contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry[J].Rheumatology,2001,28(5):1063-1067.

[4]Roldan JF,Del Rincon I,Escalante A,et al.Loss of cortical bonefrom the metacarpal diaphysis in patients with rheumatoid arthritis:independent efects of systemic inflammation and glucocorticoids[J].Rheumatology,2006,33(3):508-516.

[5]Lee SG,Park YE,Park SH,et al.Increased frequency of osteoporosis and BMD below the exp ected range for age among South Korean women with rheumatoid arthritis[J].Int J Rheum Dis,2012,15(3):289-296.

[6]楼慧玲,彭程,陈巧聪.三种骨代谢标志物的测定在老年骨质疏松症患者髋部脆性骨折中的临床价值[J].南方医科大学学报,2013,32(9):1346-1349.

[7]冼华,曹文富.血中骨代谢生化指标在骨质疏松症诊治中的意义[J].中国骨质疏松杂志,2007,13(1):69-73.

[8]Zhang XW.The new consensus on eorticosteroid-induced osteoporosis by American College of Rheumatology attracts attention[J].Chin J Rheumatol,2011,15(3):145-146.

[9]Arnett FC,Edworthy SM,Bloeh DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum,1988,31(3):315-324.

[10]贾济刚,祁干.类风湿关节炎继发骨质疏松症28例临床分析[J].中国医药指南,2010,47(28):664-665.

[11]Dos Anjos DA,Do Vale GF,Campos C,et al.Exta-articular inflamematory sites detected by F-18 FDG PET/CT in a patient wit Il Rheumatoid Arthritis[J].Clin Nucl Med,2010,35(7):540-541.

[12]Thiele K,Buttgereit F,Huscher D,et al.Current use of glucocorticoids in patients with rheumatoid arthritis in Germany[J].Arthritis Rheum,2005,53:740-747.

[13]Bultink IE,Baden M,Lems WF.Glucocorticoid-induced osteoporosis:an update on current pha rmacotherpy and future directions[J].Expert Opin Pharmacother,2013,14(2):185-197.

[14]洪琼,徐建华,徐胜前,等.类风湿关节炎患者血清25羟基维生素D水平变化及其临床意义[J].中华风湿学杂志,2013,17(3):159-163.

[15]Toth M,Grossman A.Glucocortieoid-induced osteoporosis:lessons from cushing's syndrome[J].Clin Endocrinol(Oxf),2013,79(1):1-11.

[16]Erem C,Tanakol R,Alagol F,et al.Relationship of bone turnover parameters endogenous hormones and Vit D Deficiency to hip fracture in elderly postmenopausal women[J].Int J Clin Pract,2002,56:333-337.

[17]Lee YH,Rho YH,Choi SI,et al.Predictors of bone mineral density and osteoporosis in patients attending a rheurnatology out patient clinic[J].Rheumatol Int,2002,23:67-69.

[18]Oppmann B,Lesley R,Blom B,et al.Novel p19 protein engages IL-12 p40 to form a cytokine,IL-23,with biological activities similar as well as distinct from IL-12[J].Immunity,2000,13(5):715-725.

[19]张婷容,智喜梅,吴文.鳗鱼降钙素对老年男性骨质疏松患者的疗效及安全性研究[J].中山大学学报:医学版,2009,30(3):199-201.

基本信息:

中图分类号:R580;R593.22

引用信息:

[1]葛金莲,买买提伊明·吐尔逊,罗德梅.骨代谢生化指标在糖皮质激素诱导类风湿性关节炎骨质疏松症中的意义[J].新疆医科大学学报,2015,38(08):1011-1013+1017.

基金信息:

新疆医学动物模型研究重点实验室开放课题(XJDX1103-2012-07)

发布时间:

2015-08-15

出版时间:

2015-08-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文